XMAW:LSE:LSE-Xtrackers MSCI AC World ESG Screened UCITS ETF 1C (GBX)

ETF | Others |

Last Closing

USD 3523.5

Change

+34.50 (+0.99)%

Market Cap

N/A

Volume

2.62K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+6.94 (+5.00%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.05 (+0.27%)

USD 581.04B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.04 (+0.30%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.65 (-1.03%)

USD 266.08B
0QZO:LSE 0QZO

+0.30 (+0.28%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.05 (+0.18%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

+4.82 (+2.90%)

USD 202.26B
0R24:LSE Intel Corp.

-0.64 (-2.93%)

USD 196.14B

ETFs Containing XMAW:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.55% 69% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.55% 69% C- 67% D+
Trailing 12 Months  
Capital Gain 24.73% 83% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.73% 81% B- 78% C+
Trailing 5 Years  
Capital Gain 72.76% 82% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.76% 80% B- 83% B
Average Annual (5 Year Horizon)  
Capital Gain 12.49% 70% C- 72% C
Dividend Return 12.49% 69% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.64% 61% D- 76% C+
Risk Adjusted Return 107.36% 93% A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike